title: Arginine vasopressin does not alter mucosal tissue oxygen tension and oxygen supply in an acute endotoxemic pig model.
abstract: OBJECTIVE
  To determine the effects of increasing dosages of continuously infused arginine-vasopressin (AVP) on mucosal tissue oxygen tension and oxygen supply in an auto-perfused, innervated jejunal segment in an acute endotoxic porcine model.
  
  
  METHODS
  Prospective, randomized, experimental study.
  
  
  METHODS
  University hospital animal research laboratory.
  
  
  METHODS
  Jejunal mucosal tissue PO2 was measured employing two Clark-type surface oxygen electrodes. Oxygen saturation of jejunal microvascular hemoglobin was determined by tissue reflectance spectrophotometry. Systemic hemodynamic variables, mesenteric-venous and systemic acid base and blood gas variables and lactate measurements were recorded. Measurements were performed at baseline, after E. coli lipopolysaccharide (LPS) administration and at 20 min intervals during incremental AVP infusion (n=8; 0.014, 0.029, 0.057, 0.114 and 0.229 IU kg(-1) h(-1), respectively) or infusion of saline (n =8).
  
  
  RESULTS
  LPS infusion leads to a significant (P<0.05) decrease of mucosal tissue oxygen tension (PO2muc, 24+/-3 to 12+/-2 mmHg) and microvascular hemoglobin oxygen saturation (HbO2, 38+/-4 to 21+/-4%). Mesenteric venous lactate level increased (2.4+/-0.3 to 4.7+/-1.7 mmol l(-1)), while mesenteric venous pH decreased (7.38+/-0.02 to 7.26+/-0.12), indicating tissue hypoxia. AVP significantly increased mean arterial pressure (MAP, 81+/-15 to 97+/-17 at 0.057 IU kg(-1) h(-1)). No differences in jejunal mucosal oxygenation occurred between study groups at any dosage during the experimental protocol.
  
  
  CONCLUSIONS
  AVP administration did not further compromise mucosal tissue oxygen tension and oxygen supply in the acute phase of endotoxic pigs.
authors.affiliation: Department of Anesthesiology and Critical Care Medicine, Innsbruck Medical University, Anichstrasse 35, 6020 Innsbruck, Austria. johann.knotzer@uibk.ac.at
authors.forename: Hans
authors.initials: H
authors.lastname: Knotzer
authors.forename: Stephan
authors.initials: S
authors.lastname: Maier
authors.forename: Martin W
authors.initials: MW
authors.lastname: Dünser
authors.forename: Walter R
authors.initials: WR
authors.lastname: Hasibeder
authors.forename: Hans
authors.initials: H
authors.lastname: Hausdorfer
authors.forename: Julia
authors.initials: J
authors.lastname: Brandner
authors.forename: Christian
authors.initials: C
authors.lastname: Torgersen
authors.forename: Hanno
authors.initials: H
authors.lastname: Ulmer
authors.forename: Barbara
authors.initials: B
authors.lastname: Friesenecker
authors.forename: Claudia
authors.initials: C
authors.lastname: Iannetti
authors.forename: Werner
authors.initials: W
authors.lastname: Pajk
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001127:Arginine Vasopressin / Q000008:administration & dosage / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D007413:Intestinal Mucosa / Q000098:blood supply / Q000187:drug effects* / Q000378:metabolism; D007583:Jejunum / Q000098:blood supply; D008833:Microcirculation; D010100:Oxygen / Q000378:metabolism*; D010313:Partial Pressure; D011897:Random Allocation; D012772:Shock, Septic / Q000188:drug therapy*; D013053:Spectrophotometry; D013152:Splanchnic Circulation; D013552:Swine; D014662:Vasoconstrictor Agents / Q000008:administration & dosage / Q000494:pharmacology*
chemical_list: D014662:Vasoconstrictor Agents; D001127:Arginine Vasopressin; D010100:Oxygen